Clinical Trial Update: A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This update covers the Phase 1/2 study of the investigational agent NUC-7738 in patients with advanced solid tumors and lymphoma, focusing on safety, pharmacoki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Melanoma
• Solid Tumors

Drugs mentioned

• NUC-7738 (NUC-7738)

Snippet

Sponsor: NuCana plc | Conditions: Advanced Cancer, Lymphoma | Phase 1, Phase 2 | Status: RECRUITING